including Alzheimer’s Disease, Not applicable (trial is a pharmacokinetic study in healthy volunteers). Intended indication: neuroinflammation-related diseases
Conditions
Interventions
None listed
Sponsors
Neurotherapia Inc.
Eligibility
Sex/Gender
All
Age
18 Years to 64 Years
Countries
Hungary
Outcome results
None listed